جست‌وجوی استاد و پژوهشگر

• Immunology
• Cancer Cachexia
• Gut Microbiome
• +۳ مورد دیگر

Dr. Brooke Bullard is an Assistant Professor in the Department of Science at Mercer University's College of Professional Advancement. She holds a PhD in Biomedical Science from the University of South Carolina (2025) and a BS in Exercise Science from Belmont University (2018). Her research integrates immunology, microbiome science, and metabolic physiology, with emphasis on: Macrophage roles in cancer/colitis Gut-microbe interactions Cancer cachexia mechanisms Non-pharmacological interventions (diet/exercise) Recent publications (2022-2025) in journals like American Journal of Physiology and Journal of Cachexia, Sarcopenia and Muscle reveal a focus on murine models, chemotherapy toxicity, and natural compounds. Awards include the Dean C. Barnhart Award (2025) and Dean's Award for Doctoral Achievement (2025). She teaches undergraduate biology and pathophysiology courses.

Gianni Panagiotouمشاهده پروفایل

استاد

• Microbiome Dynamics
• Systems Biology
• Infectious Diseases
• +۵ مورد دیگر

Prof. Dr. Gianni Panagiotou heads the Department of Microbiome Dynamics at Leibniz Institute for Natural Product Research and Infection Biology and holds a professorship at Friedrich Schiller University Jena. His research integrates meta-omics and eco-systems biology to investigate host-microbiome interactions in metabolic diseases, infections, and sepsis. Research focuses include: Microbiome dynamics in health/disease states Systems biology of infectious pathogens Personalized nutrition strategies Gut-lung axis dysbiosis mechanisms Machine learning for microbiome diagnostics Recent publications demonstrate strong emphasis on clinical translation, with 2025 studies in Nature Medicine , Cell Reports , and mBio revealing microbiome signatures for NAFLD, fungal-pathogen interactions in lungs, and sepsis bioenergetics. The lab employs germ-free models and multi-omics integration to advance precision medicine. He leads the EU consortium 'MiCCrobioTAckle' exploring gut microbiome roles in cancer cachexia and teaches advanced courses in microbiome systems biology. His group maintains active collaborations across 15+ countries.

Smitha Menonمشاهده پروفایل

دانشیار بالینی

• Thoracic Oncology
• Immunotherapy
• Targeted Therapy
• +۴ مورد دیگر

Smitha Menon, M.D., serves as a Clinical Associate Professor in the Division of Hematology and Oncology at the University of Washington and holds a Physician & Research Faculty position at Fred Hutchinson Cancer Center in Seattle, Washington. Her clinical practice is centered at Fred Hutch at UW Medical Center - Montlake, specializing in complex oncology cases. Her academic foundation includes: M.B.B.S. from Stanley Medical College, Chennai, India Residency in Internal Medicine at Mayo Clinic, Rochester, MN Fellowship in Hematology and Oncology at Mayo Clinic, Rochester, MN Dr. Menon maintains board certifications in both Internal Medicine and Oncology through the American Board of Internal Medicine. Her clinical expertise focuses on head and neck cancers and lung cancer, with research centered on thoracic malignancy management using immunotherapy and targeted therapeutic approaches . She actively investigates cancer cachexia and sarcopenia —critical metabolic complications affecting body composition in cancer patients—aiming to develop integrated treatment strategies that address both tumor biology and patient physiology.

Jens Fielitzمشاهده پروفایل

استاد

• Molecular Cardiology
• Muscular Proteostasis
• Ubiquitin Proteasome System
• +۵ مورد دیگر

Prof. Dr. Jens Fielitz serves as a DZHK Professor for Molecular Cardiology and Muscular Proteostasis at Ernst-Moritz-Arndt University Greifswald's Faculty of Medicine, Department of Internal Medicine B. He leads a translational research group within Research Cluster III focused on cardiac and skeletal muscle pathophysiology. His research centers on the ubiquitin proteasome system (UPS) and its role in cardiac diseases, pathological remodeling, and inflammation-induced muscle wasting. Key investigations include MuRF protein regulation, PKD1 kinase signaling, and protein homeostasis disruption in critical illness. His work bridges molecular mechanisms to therapeutic strategies for heart failure and ICU-acquired weakness. Analysis of his 2015-2023 publications reveals consistent focus on inflammatory pathways (NLRP3/IL-1β, TGF-β), transcription factors (TFEB), and E3 ligases (MuRF1) in muscle atrophy. Major themes include sepsis-induced cardiomyopathy, pressure overload responses, and skeletal muscle wasting mechanisms across critical care and cardiovascular contexts. Prof. Fielitz actively mentors master's students and medical doctoral candidates through his lab's open positions. His research receives substantial funding from Deutsche Forschungsgemeinschaft (DFG), Deutsches Zentrum für Luft- und Raumfahrt (DLR), European Space Agency (ESA), Max-Delbrück-Centrum (MDC), Charité - Universitätsmedizin Berlin, Berlin Institute of Health (BIH), and European Regional Development Fund (ERDF). He directs the Molecular Cardiology and Muscular Proteostasis Research Group in Research Cluster III, utilizing advanced molecular and cellular facilities to investigate cardiac remodeling and muscle wasting mechanisms. His team maintains active collaborations across German cardiovascular research networks including DZHK.

Stephan von Haehlingمشاهده پروفایل

استاد

• Heart Failure
• Metabolic Cardiology
• Cardio-Oncology
• +۳ مورد دیگر

Stephan von Haehling is DZHK Professor of Metabolic Cardiology at the University of Göttingen's Faculty of Medicine and Heart Center Göttingen. He serves as spokesperson for the German Society of Cardiology's Heart Failure Working Group and deputy editor of ESC Heart Failure , focusing on clinically relevant heart failure and cardio-oncology research. His primary research examines comorbidities in heart failure, particularly sarcopenia (affecting over 20% of patients) and bone metabolism deterioration. His team demonstrated sarcopenia's role as an independent mortality predictor, leading to its inclusion in European Society of Cardiology guidelines. In cardio-oncology, they investigate cancer-induced cardiovascular changes that impair physical resilience and quality of life, identifying biomarkers like osteoprotegerin and kynurenine for early prediction. Recent publications (2020-2023) emphasize heart failure management during the COVID-19 pandemic, cardio-oncology quality-of-life metrics, bone health in heart failure, and diagnostic biomarkers for acute heart failure. His work combines clinical trials, retrospective analyses, and biomarker validation, significantly influencing European treatment guidelines. Prof. von Haehling leads a research team at Göttingen's Heart Center, conducting translational studies on metabolic cardiology with international collaborations through the German Centre for Cardiovascular Research (DZHK).

• Oncology
• Cancer Rehabilitation
• Exercise Oncology
• +۳ مورد دیگر

Morten Quist serves as an Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, with a specialized focus in Clinical Oncology. His clinical affiliation appears to be with the Copenhagen University Hospital (Region Hovedstaden), as indicated by his email domain (regionh.dk). Dr. Quist's research interests center on oncology rehabilitation, particularly examining the intersection of exercise science and cancer care. His work focuses on lung cancer rehabilitation, exercise interventions for patients with advanced disease, and management of complications such as sarcopenia and bone metastases. He has developed expertise in understanding barriers to rehabilitation participation and creating supportive care interventions for vulnerable populations including older adults with cancer. Analysis of his recent publications reveals a strong focus on clinical applications of exercise oncology, with particular attention to quality of life outcomes, patient participation barriers, and evidence-based exercise recommendations for specific cancer populations. His work often takes the form of systematic reviews, meta-analyses, and clinical guidelines that bridge research and practice. His collaborative research network spans multiple institutions and countries, as evidenced by the international authorship on many of his publications. He frequently collaborates with researchers in exercise physiology, medical oncology, geriatrics, and supportive cancer care. Dr. Quist contributes significantly to the development of clinical guidelines in cancer rehabilitation, particularly evidenced by his work on exercise recommendations for patients with bone metastases. His research demonstrates a commitment to translating evidence into practical clinical applications that improve patient outcomes across the cancer continuum.

• Metabolomics
• Metabolic Disorders
• Obesity Research
• +۵ مورد دیگر

Thomas Moritz is a Professor at the University of Copenhagen, Faculty of Health and Medical Sciences, Department of Biomedical Sciences, where he leads the Moritz Group focused on metabolic research. His work bridges basic science with clinical applications in metabolic disorders. His research interests span metabolomics, lipidomics, skeletal muscle metabolism, adipocyte biology, and circadian regulation of metabolism. Dr. Moritz employs multi-omics approaches to investigate metabolic pathways in obesity, inflammatory bowel disease, and inherited metabolic disorders. His work often focuses on how cellular metabolism responds to environmental factors like exercise timing and nutritional interventions. Dr. Moritz's recent publications demonstrate significant contributions to understanding metabolic regulation across multiple physiological systems. His work shows particular strength in integrating metabolomics with other 'omics' technologies to reveal novel insights into metabolic diseases. His research has been widely disseminated, with 233 research outputs including 229 journal articles, 2 conference abstracts, 1 comment/debate, and 1 review. Metabolomics and diagnostic algorithms for metabolic disorders Adipocyte biology and obesity-related inflammation Skeletal muscle metabolism and exercise physiology Circadian regulation of metabolic processes Lipidomics in inflammatory diseases His research has garnered significant attention across academic and social media platforms, with mentions across X (Twitter), Bluesky, Mendeley, news outlets, and scientific blogs, indicating substantial impact in the metabolic research community.

• Cancer Biology
• Metabolism
• Palliative Care
• +۳ مورد دیگر

Jonas Sørensen serves as a Guest Researcher at the Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, focusing on molecular metabolism in cancer and ageing contexts. His research integrates cancer biology, metabolic dysregulation, and clinical palliative care, with specific emphasis on insulin resistance mechanisms in oncology and cachexia management strategies. This interdisciplinary work bridges laboratory-based cancer metabolism studies with translational clinical applications for ageing cancer patients. His 2023 publications demonstrate methodological diversity—combining systematic reviews with clinical guideline development—while maintaining thematic consistency in cancer metabolism complications. Both articles address critical gaps in oncology care, with the insulin resistance study providing epidemiological insights and the cachexia paper offering practical clinical tools. He operates within the 'Molecular Metabolism in Cancer and Ageing' research group at the University of Copenhagen, contributing to the institution's biomedical oncology portfolio through active international collaborations evident in co-author networks.

Jonas Thue Treebakمشاهده پروفایل

دانشیار

• Metabolic Research
• Diabetes Research
• Obesity Pathogenesis
• +۶ مورد دیگر

Jonas Thue Treebak is an Associate Professor at the Faculty of Health and Medical Sciences, University of Copenhagen, where he leads the Treebak Group focused on metabolic research. His work investigates the signaling pathways controlling cellular and whole body glucose and lipid homeostasis using cell-based and animal models. Dr. Treebak's primary research interests include: Metabolic regulation of glucose and lipid homeostasis Insulin signaling pathways and adiposity regulation Type 2 diabetes and obesity pathogenesis Transgenic animal models for metabolic research Circadian regulation of metabolism $$\text{NAD}^+$$ metabolism and its role in cellular function His recent research has explored the intersection of exercise timing, circadian biology, and metabolic health, with significant contributions to understanding how time-of-day affects metabolic responses to physical activity and nutrition. His work has been featured in high-impact journals including Nature Aging, PNAS, and Cell Reports Medicine. Dr. Treebak has published extensively with 148 research outputs including 121 journal articles, 7 reviews, and other scholarly contributions. His research has garnered significant attention, being picked up by numerous news outlets, blogged about, and referenced across social media platforms including X (formerly Twitter), Bluesky, and Facebook.